glp 1 evolution Another milestone in the of GLP-1-based diabetes therapies Discovery of a potent and
Description
While that effect is part of how these medications work, it can sometimes make people less inclined to drink large amounts of fluid at once
Post-market surveillance through the FDAs Adverse Event Reporting System (FAERS) database documented hundreds of gastroparesis reports within the first years of approval, establishing a clear safety signal that warranted immediate label updates
GLP-1 achieves its effects by attaching to GLP-1 receptors
One such option is GLP-1 therapy, which includes medications such as semaglutide ( Ozempic , Wegovy) and liraglutide (Saxenda, Victoza)
